Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.
The Healthy @Reader's Digest on MSN
New Prostate Cancer Treatment Options You Should Know About, From a Urologic Surgeon
A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...
The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...
Reality star Kim Kardashian has revealed that she was diagnosed with a brain aneurysm, a potentially life-threatening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback